Palvella Therapeutics, Inc. · NASDAQ:PVLA

James N. Topper reported a 6.30% stake in Palvella Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

James N. Topper reported a 6.30% stake in Palvella Therapeutics, Inc., 690,012 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake: 6.30%
Shares: 690,012
Intent: Passive
What changed: Stake changed
Filed together: 17 holders

The filing in full

Holder	Stake	Shares
Frazier Life Sciences Public Fund, L.P.	4.80%	525,732
FHMLSP, L.P.	4.80%	525,732
FHMLSP, L.L.C.	4.80%	525,732
Frazier Life Sciences Public Overage Fund, L.P.	1.40%	155,023
FHMLSP Overage, L.P.	1.40%	155,023
FHMLSP Overage, L.L.C.	1.40%	155,023
Frazier Life Sciences X, L.P.	0%	3,914
FHMLS X, L.P.	0%	3,914
FHMLS X, L.L.C.	0%	3,914
Frazier Life Sciences XI, L.P.	0%	5,343
FHMLS XI, L.P.	0%	5,343
FHMLS XI, L.L.C.	0%	5,343
James N. Topper	6.30%	690,012
Patrick J. Heron	6.30%	690,012
Albert Cha	6.20%	680,755
James Brush	6.20%	680,755
Daniel Estes	0%	5,343

Source

View original at SEC

Related